Streetbeat News

Products Services

ASTC

The TSA has approved Astrotech's TRACER 1000 for inclusion in the Air Cargo Security Technology List, potentially boosting the company's market position in the security technology sector.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 1:03 pm

PL

Planet Labs has expanded its contract with the Government of New South Wales, Australia, partnering with NGIS to enhance crisis response, urban planning, and biodiversity management.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 1:02 pm

TXG

10x Genomics has started commercial shipments of its Xenium Prime 5K Pan-Tissue and Pathways panel.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 1:02 pm

UPST

Diamond Credit Union has partnered with Upstart to offer personal loans. Serving over 64,000 members and managing over $1 billion in assets, Diamond Credit Union joins the AI lending marketplace.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 1:01 pm

SSYS

Stratasys has partnered with BASF to introduce a new polypropylene material for Stratasys' SAF technology, aiming to enhance part quality, versatility, and cost efficiency in additive manufacturing.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 12:59 pm

COYA

Coya Therapeutics is expanding its research collaboration with Houston Methodist Research Institute, funded by the Johnson Center for Cellular Therapeutics. The collaboration aims to advance Coya's Treg exosome technology into clinical trials, validate biomarkers for neurodegenerative diseases, and explore drug combinations with COYA 301.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 12:58 pm

KYTX

Kyverna Therapeutics shares are trading higher after the company announced KYV-101 received FDA IND clearance for the treatment of patients with treatment-refractory Stiff-Person Syndrome in the KYSA-8 Phase 2 trial.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 12:57 pm

KYTX

The FDA has authorized the clearance for Kyverna's KYV-101 CAR T-cell therapy for the treatment of patients with treatment-refractory Stiff-Person Syndrome in the KYSA-8 Phase 2 trial. This expands the use of KYV-101 in targeting B cell-driven autoimmune diseases.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 12:56 pm

MOBX

Mobix Labs has announced a strategic partnership with TalkingHeads Wireless to develop cost-effective, energy-efficient 5G base stations. The collaboration will combine THW's AI-optimized 5G radio solution with Mobix Labs' advanced ICs, antennas, and optical products to enhance performance and efficiency.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 12:56 pm

WNS

WNS Limited and Mosaic Insurance have announced a strategic partnership aimed at developing a future-ready operations model for underwriting, claims support, reinsurance processing, and finance and technology services.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 12:55 pm